0001805243-20-000002.txt : 20200423 0001805243-20-000002.hdr.sgml : 20200423 20200423155550 ACCESSION NUMBER: 0001805243-20-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 504(b)(1)(iii) ITEM INFORMATION: 06c FILED AS OF DATE: 20200423 DATE AS OF CHANGE: 20200423 EFFECTIVENESS DATE: 20200423 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RESQ PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0001805243 IRS NUMBER: 833795334 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-365676 FILM NUMBER: 20810950 BUSINESS ADDRESS: STREET 1: 59-780 KAPUHI PLACE CITY: HALEIWA STATE: HI ZIP: 96712 BUSINESS PHONE: 9493713993 MAIL ADDRESS: STREET 1: 59-780 KAPUHI PLACE CITY: HALEIWA STATE: HI ZIP: 96712 D 1 primary_doc.xml X0708 D LIVE 0001805243 RESQ PHARMACEUTICALS INC. 3535 Executive Terminal Drive Ste 110 Henderson NV NEVADA 89052 9493713993 DELAWARE None None Corporation true 2019 John T. Hyatt 59-780 Kapuhi Place Haleiwa HI HAWAII 96712 Promoter Ben Esque 59-780 Kapuhi Place Haleiwa HI HAWAII 96712 Executive Officer Pharmaceuticals No Revenues 06c 04.3 false 2020-04-07 true true false 50000 N/A None None None N/A N/A HI HAWAII 96712 All States false 2000000 247000 1753000 false 2 0 0 200000 true The funds will be used to develop a pharmaceutical product and seek FDA approval. Some amount, approximately $200,000 will be used to compensate the Officers. false RESQ PHARMACEUTICALS INC. John T. Hyatt John T. Hyatt Promoter 2020-04-23